UPDATE : Monday, May 25, 2020
Will synthetic biology be vital in smart therapeutics?
Synthetic biology, which designs biological components and systems in new w...
by Nam Doo-hyun  |  2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks
Biotech and pharmaceutical shares plunged on Tuesday, hurt mainly by the ov...
by Nam Doo-hyun  |  2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’
AbClon, a developer of innovative antibody medicines, is likely to achieve ...
by Nam Doo-hyun  |  2018-10-22 14:49
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
L&C BIO, a tissue engineering company, said on Friday that it has set its o...
by So Jae-hyeon  |  2018-10-22 14:12
'Superbug' fears bring antibiotics developers under spotlight
Investors are paying keen attention to antibiotics developers amid growing ...
by Nam Doo-hyun  |  2018-10-22 11:53
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’
Fortune, a U.S.-based multinational business magazine, has named Samsung Bi...
by Lee Han-soo  |  2018-10-19 16:34
CancerRop launches unit to develop cell therapies
CancerRop established CancerRop Cell on Wednesday, a subsidiary to develop ...
by Lee Han-soo  |  2018-10-18 15:25
Biogen, Samsung Bioepis announce European launch of Imraldi
Biogen and Samsung Bioepis said Tuesday they will launch Imraldi, the compa...
by Lee Han-soo  |  2018-10-17 17:28
Bio stocks listed under ‘tech exception policy’ perform better
Biotech and medical companies that went public under the Korea Exchange’s “...
by Nam Doo-hyun  |  2018-10-15 12:27
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept.
Merck, known as MSD outside the United States and Canada, announced that is...
by Lee Han-soo  |  2018-10-11 16:31
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
Celltrion said Thursday that the U.S. Oncologic Drug Advisory Committee (OD...
by Lee Han-soo  |  2018-10-11 12:10
‘Korea publishes many biotech papers but rarely links them to biz’
South Korea’s ranking in biotech competitiveness, announced by the U.S. sci...
by Nam Doo-hyun  |  2018-10-10 16:35
GC opens new cell research center
GC said Monday that it has dedicated a new integrated research center in a ...
by Lee Han-soo  |  2018-10-10 11:45
More biotech stocks come in top 20 on KOSDAQ
The number of pharmaceutical and biotech firms within the top 20 companies ...
by Nam Doo-hyun  |  2018-10-10 11:20
Newly listed biotech firms perform poorly on KOSDAQ
Biotech companies that went public in the first half of this year have show...
by Nam Doo-hyun  |  2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’
Samsung C&T Corp., the parent company of Samsung Group, is likely to enjoy ...
by Nam Doo-hyun  |  2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures
Korean biotech venture companies are increasingly seeking more Ph.D.-qualif...
by Nam Doo-hyun  |  2018-10-02 14:40
FDA to review Samsung Bioepis’ application for anti-arthritis biosimilar
Samsung Bioepis said Thursday that the U.S. Food and Drug Administration ha...
by Lee Han-soo  |  2018-09-27 11:22
Biois registers patent to develop TNF-alpha inhibitor
Biois Corp. said it has registered a patent on aptamers binding to tumor ne...
by So Jae-hyeon  |  2018-09-20 16:45
Celltrion, Emory University to develop new drug for Atherosclerosis
Celltrion said Thursday that it has signed an “incubation” agreement with E...
by Lee Han-soo  |  2018-09-20 13:22
Back to Top